Evidence map›Paper›PMID 36351433›Full record

ArticleAmerican journal of human genetics2022

EMILIN1 deficiency causes arterial tortuosity with osteopenia and connects impaired elastogenesis with defective collagen fibrillogenesis.

Christin S Adamo, Aude Beyens, Alvise Schiavinato, Douglas R Keene, Sara F Tufa, Matthias Mörgelin, Jürgen Brinckmann, Takako Sasaki, Anja Niehoff, Maren Dreiner and 30 more

Open access · greenAbstract read
In one paragraph

Article in American journal of human genetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

40 authors at 20 institutions in 10 countries.

Christin S AdamoDepartment of Pediatrics and Adolescent Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50931 Cologne, Germany; Center for Biochemistry, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50931 Cologne, Germany.
Aude BeyensCenter for Medical Genetics, Ghent University Hospital, 9000 Ghent, Belgium; Department of Biomolecular Medicine, Ghent University, 9000 Ghent, Belgium; Department of Dermatology, Ghent University Hospital, 9000 Ghent, Belgium.
Alvise SchiavinatoDepartment of Pediatrics and Adolescent Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50931 Cologne, Germany; Istituto Di Patalogia Clinica, Azienda Sanitaria Universitaria Integrata di Udine (ASUID), 33100 Udine, Italy.
Douglas R KeeneResearch Division, Shriners Hospital for Children, Portland, OR 97239, USA.
Sara F TufaResearch Division, Shriners Hospital for Children, Portland, OR 97239, USA.
Matthias MörgelinDivision of Infection Medicine, Department of Clinical Sciences, Lund University, 22242 Lund, Sweden; Colzyx AB, 22363 Lund, Sweden.
Jürgen BrinckmannDepartment of Dermatology and Institute of Virology and Cell Biology, University of Lübeck, 23562 Lübeck, Germany.
Takako SasakiDepartment of Biochemistry II, Faculty of Medicine, Oita University, Oita 870-1192, Japan.
Anja NiehoffCologne Center for Musculoskeletal Biomechanics (CCMB), Medical Faculty and University Hospital Cologne, University of Cologne, 50931 Cologne, Germany; Institute of Biomechanics and Orthopaedics, German Sport University Cologne, 50933 Cologne, Germany.
Maren DreinerInstitute of Biomechanics and Orthopaedics, German Sport University Cologne, 50933 Cologne, Germany.
Lore PottieCenter for Medical Genetics, Ghent University Hospital, 9000 Ghent, Belgium; Department of Biomolecular Medicine, Ghent University, 9000 Ghent, Belgium.
Laura Muiño-MosqueraCenter for Medical Genetics, Ghent University Hospital, 9000 Ghent, Belgium; Department of Pediatric Cardiology, Ghent University Hospital, 9000 Ghent, Belgium.
Elif Yilmaz GulecDepartment of Medical Genetics, Istanbul Medeniyet University Medical School, 34720 Istanbul, Turkey; Department of Medical Genetics, Istanbul Goztepe Prof. Dr. Suleyman Yalcin City Hospital, 34722 Istanbul, Turkey.
Alper GezdiriciDepartment of Medical Genetics, Basaksehir Cam and Sakura City Hospital, 34480 Istanbul, Turkey.
Paola BraghettaDepartment of Molecular Medicine, University of Padova, 35131 Padova, Italy.
Paolo BonaldoDepartment of Molecular Medicine, University of Padova, 35131 Padova, Italy.
Raimund WagenerDepartment of Pediatrics and Adolescent Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50931 Cologne, Germany.
Mats PaulssonDepartment of Pediatrics and Adolescent Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50931 Cologne, Germany; Cologne Center for Musculoskeletal Biomechanics (CCMB), Medical Faculty and University Hospital Cologne, University of Cologne, 50931 Cologne, Germany; Center for Molecular Medicine Cologne (CMMC), University of Cologne, 50931 Cologne, Germany.
Helen BornaunDepartment of Pediatric Cardiology, Kanuni Sultan Suleyman Research and Training Hospital, 34303 Istanbul, Turkey.
Riet De RyckeDepartment of Biomedical Molecular Biology Ghent University, 9000 Ghent, Belgium; VIB Center for Inflammation Research and BioImaging Core, VIB, 9052 Ghent, Belgium.
Michiel De BruyneDepartment of Biomedical Molecular Biology Ghent University, 9000 Ghent, Belgium; VIB Center for Inflammation Research and BioImaging Core, VIB, 9052 Ghent, Belgium.
Femke BaekeDepartment of Biomedical Molecular Biology Ghent University, 9000 Ghent, Belgium; VIB Center for Inflammation Research and BioImaging Core, VIB, 9052 Ghent, Belgium.
Walter P DevineDepartment of Pathology, University of California San Francisco, San Francisco, CA 94115, USA.
Balram GangaramDivision of Genetics, Department of Pediatrics, University of California San Francisco, San Francisco, CA 94158, USA.
Allison TamDivision of Genetics, Department of Pediatrics, University of California San Francisco, San Francisco, CA 94158, USA.
Meena BalasubramanianHighly Specialised Osteogenesis Imperfecta Service, Sheffield Children's Hospital NHS Foundation Trust, Sheffield S10 2TH, UK; Department of Oncology and Metabolism, The University of Sheffield, Sheffield S10 2TN, UK; Sheffield Clinical Genetics Service, Sheffield Children's NHS Foundation Trust, Sheffield S10 2TH, UK.
Sian EllardExeter Genomics Laboratory, Royal Devon and Exeter NHS Foundation Trust, Exeter EX2 5DW, UK.
Sandra MooreExeter Genomics Laboratory, Royal Devon and Exeter NHS Foundation Trust, Exeter EX2 5DW, UK.
Sofie SymoensCenter for Medical Genetics, Ghent University Hospital, 9000 Ghent, Belgium; Department of Biomolecular Medicine, Ghent University, 9000 Ghent, Belgium.
Joseph ShenDivision of Genomic Medicine, Department of Pediatrics, MIND Institute, University of California Sacramento, Sacramento, CA 95817, USA.
Stacey ColeDivision of Genomic Medicine, Department of Pediatrics, MIND Institute, University of California Sacramento, Sacramento, CA 95817, USA.
Ulrike SchwarzeDepartments of Pathology and Medicine (Medical Genetics), University of Washington, Seattle, WA, USA.
Kathryn W HolmesDepartment of Pediatrics, Oregon Health & Science University, Portland, OR 97239, USA.
Susan J HayflickDepartment of Molecular and Medical Genetics, Oregon Health & Science University, Portland, OR 97239, USA.
Wojciech WiszniewskiDepartment of Molecular and Medical Genetics, Oregon Health & Science University, Portland, OR 97239, USA.
Sheela NampoothiriDepartment of Pediatric Genetics, Amrita Institute of Medical Sciences and Research Center, Cochin, Kerala 682041, India.
Elaine C DavisDepartment of Anatomy and Cell Biology, McGill University, Montreal, QC H3A 0C7, Canada.
Lynn Y SakaiDepartment of Molecular and Medical Genetics, Oregon Health & Science University, Portland, OR 97239, USA.
Gerhard SengleDepartment of Pediatrics and Adolescent Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50931 Cologne, Germany; Center for Biochemistry, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50931 Cologne, Germany; Cologne Center for Musculoskeletal Biomechanics (CCMB), Medical Faculty and University Hospital Cologne, University of Cologne, 50931 Cologne, Germany; Center for Molecular Medicine Cologne (CMMC), University of Cologne, 50931 Cologne, Germany. Electronic address: gsengle@uni-koeln.de.
Bert CallewaertCenter for Medical Genetics, Ghent University Hospital, 9000 Ghent, Belgium; Department of Biomolecular Medicine, Ghent University, 9000 Ghent, Belgium. Electronic address: bert.callewaert@ugent.be.
Ghent University Hospital · BEUniversity of Cologne · DEOregon Health & Science University · USGhent University · BEUniversity of California, San Francisco · USCalifornia State University, Sacramento · USGerman Sport University Cologne · DERoyal Devon & Exeter NHS Foundation Trust · GBShriners Hospitals for Children - Portland · USUniversity of Padua · ITAmrita Institute of Medical Sciences and Research Centre · INIstanbul Eye Hospital · TRİstanbul Kanuni Sultan Süleyman Eğitim ve Araştırma Hastanesi · TRIstanbul Metropolitan Municipality · TRLund University · SEMcGill University · CAOita University · JPSheffield Children's NHS Foundation Trust · GBUniversity of Lübeck · DEUniversity of Washington Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

EMILIN1 (elastin-microfibril-interface-located-protein-1) is a structural component of the elastic fiber network and localizes to the interface between the fibrillin microfibril scaffold and the elastin core. How EMILIN1 contributes to connective tissue integrity is not fully understood. Here, we report bi-allelic EMILIN1 loss-of-function variants causative for an entity combining cutis laxa, arterial tortuosity, aneurysm formation, and bone fragility, resembling autosomal-recessive cutis laxa type 1B, due to EFEMP2 (FBLN4) deficiency. In both humans and mice, absence of EMILIN1 impairs EFEMP2 extracellular matrix deposition and LOX activity resulting in impaired elastogenesis, reduced collagen crosslinking, and aberrant growth factor signaling. Collagen fiber ultrastructure and histopathology in EMILIN1- or EFEMP2-deficient skin and aorta corroborate these findings and murine Emilin1

Indexed as

Bone Diseases, MetabolicCutis LaxaAnimalsArteriesCollagenElastinExtracellular Matrix ProteinsHumansJoint InstabilityMembrane GlycoproteinsMiceSkin Diseases, GeneticVascular MalformationsCollagenElastinelastin microfibril interface located proteinExtracellular Matrix ProteinsMembrane Glycoproteinsaortic aneurysmarterial tortuositycollagencutis laxaEFEMP2elastic fiberEMILIN1extracellular matrixfractureLOX

Identifiers

PMID36351433
PMCPMC9748297
OpenAlexW4308514431

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.